Artus Pharma Private Limited
About Artus Pharma Private Limited
Data last updated:
Artus Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 January 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ1999PTC035344. Its GSTIN is 24AACCA8111B1ZG (Gujarat).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.25 Lakh. It is led by directors Saurin Sushilbhai Shah and Nitin Shantilal Bhagat.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 16 – A Khadayata Societybalvatika Kankariya Maninagar, Ahmedabad, Gujarat, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.77 Lakh, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹41,777 (net margin 3.3%) and EBITDA of ₹71,789 (EBITDA margin 5.6%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 5% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Artus Pharma Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address16 – A Khadayata Societybalvatika Kankariya Maninagar, Ahmedabad, Gujarat, India
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Artus Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Artus Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Artus Pharma Private Limited, buy the company report.
Financials of Artus Pharma Private Limited
FY 2025 filings availableArtus Pharma Private Limited reported revenue of ₹12.77 Lakh (up 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 14% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 5%. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹71,789 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹41,777 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.6% | ||||
| Net Profit Margin | 3.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Artus Pharma Private Limited, buy the company report.
Board of directors of Artus Pharma Private Limited
Artus Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saurin Sushilbhai Shah Also directs: Saumesh Analysts LLP | Director | 27 Jan 1999 | 27 Years 9 Months | Current |
| Nitin Shantilal Bhagat Also directs: Parry Pharma Private Limited | Director | 27 Jan 1999 | 27 Years 9 Months | Current |
Auditor
Artus Pharma Private Limited is audited by J. A. BHATT & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J. A. BHATT & CO. | FY 2023 | 101331W |
Shareholding
The shareholding of Artus Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Artus Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Artus Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Artus Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Artus Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AACCA8111B1ZG | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Artus Pharma Private Limited, buy the company report.
Recent activity
Artus Pharma Private Limited has 2 board changes on record since 1999: 2 appointments. The latest: Nitin Shantilal Bhagat was appointed as Director on 27 Jan 1999.
Frequently asked questions
Artus Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 January 1999 (27+ years old) and is registered under CIN U24231GJ1999PTC035344.
Artus Pharma has 2 current directors:
- Saurin Sushilbhai Shah - Director
- Nitin Shantilal Bhagat - Director
The latest financial statements of Artus Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Artus Pharma is 24AACCA8111B1ZG, registered in Gujarat.
The CIN (Corporate Identification Number) of Artus Pharma is U24231GJ1999PTC035344. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Artus Pharma was incorporated on 27 January 1999, making it 27+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Nitin Shantilal Bhagat was appointed as Director on 27 Jan 1999. Saurin Sushilbhai Shah was appointed as Director on 27 Jan 1999.
The registered office of Artus Pharma is at 16 – A Khadayata Societybalvatika Kankariya Maninagar, Ahmedabad, Gujarat, India.
Artus Pharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Artus Pharma is compliant as of 28 July 2026. The company is actively filing with the Registrar of Companies.